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CLINICAL VIGNETTE
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ABSTRACT
The case presented in the article is that of a 47-year-old female patient with hyperthyroidism 
induced by a hydatidiform mole. Attention was drawn to the necessity of preparing the patient
for a procedure with drugs that stabilize the hormonal activity of the thyroid. The removal of 
the hydatidiform mole resulted in gradual normalization of thyroid hormone levels.
The trophoblast has a hormonal activity, secrete hCG (human chorionic gonadotropin).The  
hCG partial structural homology causes affinity to the TSH (thyroid stimulating hormone) 
receptor. The higher the weight of the trophoblast, the higher the production and concentration
of hCG in the blood.
Therefore, gestational trophoblastic disease may be accompanied by hyperthyroidism. The 
problem is frequently described, however, due to the risk of developing thyroid storm, it 
cannot be overlooked [1].
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CASE STUDY
A 47-year-old patient was admitted to the hospital due to uterine bleeding. The patient’s 
general condition was good. The last menstruation started 53 days earlier. The patient was in 
her eighth pregnancy (5 births, 2 miscarriages in the history).
On gynaecological examination: the uterine body was enlarged, reaching 6 cm above the 
symphysis pubis. On TV ultrasound: a heterogeneous 78 x 77 x 91 mm ‘Swiss-cheese pattern’
area in the uterine cavity. Both ovaries have normal morphology. 
Laboratory results are shown in Table 1.
The patient did not report any symptoms of hyperthyroidism.  On physical examination the 
thyroid was not enlarged, the ultrasound examination showed its normal size, slightly reduced
echogenicity without increased vascularization. 
Due to the patient’s age, no further procreation plans, suspicion of complete hydatidiform 
mole, a decision was to excise the uterus.
Due to abnormal hormone concentrations, the patient needed to be prepared for surgery. 
Achieving euthyroidism, usually requiring time, was not possible in this case. Thiamazole at a
dose of 20 mg every eight hours was activated, before the surgery hydrocortisone 100 mg was
administered. Injections were repeated every six hours on the day of the surgery and 
continued the first day after the surgery.
The surgical procedure has run without complications. Histopathological examination results 
complete hydatidiform mole. No clinical signs of hyperthyroidism were observed 
postoperatively. The patient was discharged home on day four after the surgery in good 
general condition. 
The patient is currently under observation with no signs of hydatidiform mole or thyroid 
disease.  
DISCUSSION
Hyperthyroidism in the course of gestational trophoblastic disease is diagnosed in 25–64% of 
patients [2]. Nevertheless, the asymptomatic course is found in 5–10% of patients the risk of 
the storm should always be considered in every patient with hyperthyroidism [3]. It was found
that severe complications of hyperthyroidism occur in about 20% of patients [4]. The 
described case indicates a direct relationship between β-hCG concentration and thyroid 
dysfunction. A very slow decrease in TSH concentration, with fairly rapid normalization of 
fT3 and fT4 concentrations after surgery.
The treatment of gestational trophoblastic disease with hyperthyroidism requires appropriate 
preparation of the patient to achieve euthyroidism and should be implemented as soon as 
possible after the diagnosis.  There are no detailed guidelines for such cases in the literature. 
We recommended thionamides that inhibit thyroid peroxidase and glucocorticoids that inhibit 
the conversion of thyroxine to triiodothyronine. In monitoring the course of treatment of 
gestational trophoblastic disease it is important to pay attention not only to markers of 
treatment efficacy but also to clinical and biochemical markers of thyrotoxicosis.















414,937 26,096 919.8 2.34 < 1.0
TSH (mIU/L
[0.33–4.59]1
0.008 < 0.005 0.011 0.05 0.36
fT3 (pmol/L)
[3.78–5.98]1
16.0 6.62 4.0 4.5 3.34
fT4 (pmol/L)
[12.1–19.6]1










1Reference values for the laboratory are given in parentheses
2ATPO – Thyroid Peroxydase Antibodies
3ATG – Thyreoglobulin Antibodies
4TRAb – TSH ReceptorAntibodies
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